XW143F8Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
- Billable / Specific Code
- Revised for FY 2027
XW143F8 is a billable ICD-10-PCS procedure code for Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products. The Alphabetic Index lists this code under Etuvetidigene Autotemcel. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 4 | Central Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | F | Etuvetidigene Autotemcel |
| 7 | Qualifier | 8 | New Technology Group 8 |
In the ICD-10-PCS Alphabetic Index
The FY 2027 ICD-10-PCS Alphabetic Index refers to XW143F8 as Etuvetidigene Autotemcel. These index entries lead to this code:
To code etuvetidigene autotemcel, open the FY 2027 ICD-10-PCS Alphabetic Index at Etuvetidigene Autotemcel. The entry lists XW143F8 directly as a complete, billable code.
Clinical Classification (CCSR)
AHRQ groups this procedure code into these clinical categories.
Code History
- 30243C0 — Transfuse Autol HSPC, Gene Mod in Central Vein, Perc
Similar Procedure Codes
Questions About XW143F8
Is XW143F8 a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 on inpatient claims from October 1, 2026 through September 30, 2027.
What is the ICD-10-PCS code for etuvetidigene Autotemcel?
The ICD-10-PCS Alphabetic Index lists Etuvetidigene Autotemcel under code XW143F8, Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8, billable on inpatient claims in fiscal year 2027.
What do the characters in XW143F8 mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character F is the Device/Substance/Technology (Etuvetidigene Autotemcel); the 7th character 8 is the Qualifier (New Technology Group 8).
What MS-DRG does XW143F8 group to?
On an inpatient stay, Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 maps to MS-DRGs 016, 017, with relative weights from 3.3032 to 6.0136. The MS-DRG sets the fixed Medicare payment for the stay.
